Epilepsia

• 

  Publication Venue For

  • Techniques for placement of stereotactic electroencephalographic depth electrodes: Comparison of implantation and tracking accuracies in a cadaveric human study..  59:1667-1675. 2018
  • A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsy..  59:802-813. 2018
  • Prospective clinical trials to investigate clinical and molecular biomarkers..  58 Suppl 3:20-26. 2017
  • Hippocampal antioxidative system in mesial temporal lobe epilepsy..  56:789-799. 2015
  • Metals and electrolytes in sclerotic hippocampi in patients with drug-resistant mesial temporal lobe epilepsy..  55:e34-e37. 2014
  • Emergency management of febrile status epilepticus: results of the FEBSTAT study..  55:388-395. 2014
  • Electroencephalography monitoring in critically ill children: current practice and implications for future study design..  54:1419-1427. 2013
  • Erratum: Gene expression of glutamate metabolizing enzymes in the hippocampal formation in human temporal lobe epilepsy (Epilepsia (2013) 54 228-238).  54:1140. 2013
  • Gene expression of glutamate metabolizing enzymes in the hippocampal formation in human temporal lobe epilepsy..  54:228-238. 2013
  • The extracellular space and epileptic activity in the adult brain: explaining the antiepileptic effects of furosemide and bumetanide..  53 Suppl 1:18-25. 2012
  • Genomic microdeletions associated with epilepsy: not a contraindication to resective surgery..  52:1388-1392. 2011
  • Histopathology of human epilepsy.  51:37. 2010
  • Plasticity of glutamate synaptic mechanisms.  51:17. 2010
  • Seizure-induced basal dendrites on granule cells.  51:43. 2010
  • Temporal lobe epilepsy and the BDNF receptor, TrkB.  51:46. 2010
  • Letter: Antiepileptogenic and neuroprotective effects of erythropoietin: recent data..  50:1654-1655. 2009
  • A prospective study of the modified Atkins diet for intractable epilepsy in adults..  49:316-319. 2008
  • Glutamate and astrocytes--key players in human mesial temporal lobe epilepsy?.  49 Suppl 2:42-52. 2008
  • Assessment of hairline EEG as a screening tool for nonconvulsive status epilepticus: Response to Bubrick et al. [5].  48:2375. 2007
  • Drug resistance in epilepsy: more twists in the tale..  48:2369-2370. 2007
  • Assessment of hairline EEG as a screening tool for nonconvulsive status epilepticus..  48:959-965. 2007
  • A multicenter study of BRD2 as a risk factor for juvenile myoclonic epilepsy..  48:706-712. 2007
  • Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy..  48:674-683. 2007
  • Effects of a single dose of erythropoietin on subsequent seizure susceptibility in rats exposed to acute hypoxia at P10..  48:175-181. 2007
  • Imaging of intrinsic optical signals in primate cortex during epileptiform activity..  48 Suppl 4:65-74. 2007
  • Normalization of quality of life three years after temporal lobectomy: a controlled study..  47:928-933. 2006
  • Nonfebrile illness seizures: a unique seizure category?.  46:952-955. 2005
  • Losing neurons: selective vulnerability and mesial temporal sclerosis..  46 Suppl 7:39-44. 2005
  • Refractory calculation-induced idiopathic generalized epilepsy: a case report and review of the literature..  46 Suppl 10:48-50. 2005
  • Neuronal cell death in a rat model of mesial temporal lobe epilepsy is induced by the initial status epilepticus and not by later repeated spontaneous seizures..  45:296. 2004
  • Optical imaging of epileptiform activity in human neocortex..  45 Suppl 4:43-47. 2004
  • An Xp; Yq translocation causing a novel contiguous gene syndrome in brothers with generalized epilepsy, ichthyosis, and attention deficits..  44:1529-1535. 2003
  • Hippocampal programmed cell death after status epilepticus: evidence for NMDA-receptor and ceramide-mediated mechanisms..  44:282-291. 2003
  • Differential expression of GABA and glutamate-receptor subunits and enzymes involved in GABA metabolism between electrophysiologically identified hippocampal CA1 pyramidal cells and interneurons..  44:143-149. 2003
  • Pharmacokinetics of levetiracetam..  42 Suppl 4:24-27. 2001
  • Successful use of intravenous immunoglobulin as initial monotherapy in Landau-Kleffner syndrome..  41:880-886. 2000
  • Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy..  40:26-29. 1999
  • Of mice and mechanisms: The role of non-T-type calcium channelopathies in absence seizures.  40:2-2. 1999
  • Social phobia: issues in assessment and management..  40 Suppl 6:S60-S65. 1999
  • Surgical outcome in patients with epilepsy with occult vascular malformations treated with lesionectomy..  39:600-607. 1998
  • REPLY.  39:232-234. 1998
  • The utility of the lh/lh mutant mouse as a animal model of human absence epilepsy..  39:232-233. 1998
  • Landau-Kleffner syndrome: consistent response to repeated intravenous gamma-globulin doses: a case report..  38:489-494. 1997
  • Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures..  38:408-414. 1997
  • Clinical and electroencephalographic correlates in Rasmussen's encephalitis..  38:189-194. 1997
  • Pharyngeal dysesthesia as an aura in temporal lobe epilepsy..  37:911-913. 1996
  • Predictors of outcome of epilepsy surgery: multivariate analysis with validation..  37:814-821. 1996
  • Behavioral side effects of gabapentin in children..  37:87-90. 1996
  • Fast spin-echo, magnetic resonance imaging-measured hippocampal volume: correlation with neuronal density in anterior temporal lobectomy patients..  36:899-904. 1995
  • ANTERIOR TEMPORAL LOBECTOMY IN PATIENTS WITH MRI EVIDENCE OF BILATERAL HIPPOCAMPAL SCLEROSIS.  36:368-368. 1995
  • COMPARISON OF VOLUMETRIC HIPPOCAMPAL MRI AND FDG-PET - CORRELATION WITH SURGICAL OUTCOME IN MESIAL TLE.  36:371-371. 1995
  • GABA(B) MEDIATED INHIBITION IN THE THALAMUS OF THE LH/LH MODEL OF GENERALIZED ABSENCE EPILEPSY.  36:206-206. 1995
  • LONG-TERM OUTCOME FOLLOWING TEMPORAL LOBECTOMY FOR TEMPORAL-LOBE EPILEPSY.  36:374-374. 1995
  • PET HYPOMETABOLISM IN MESIAL TEMPORAL-LOBE EPILEPSY (MTLE) - CORRELATION WITH HIPPOCAMPAL NEURONAL DENSITY.  36:A8-A8. 1995
  • Magnetic resonance imaging evidence of hippocampal sclerosis in progression: a case report..  35:1332-1336. 1994
  • Relationship of carbamazepine reduction rate to seizure frequency during inpatient telemetry..  35:1160-1164. 1994
  • Quisqualic acid-induced seizures during development: a behavioral and EEG study..  35:868-875. 1994
  • ANTIEPILEPTIC DRUGS - OPTIMAL USE AND FUTURE-PROSPECTS.  35:S58-S60. 1994
  • ANTIEPILEPTIC DRUGS - OPTIMAL USE AND FUTURE-PROSPECTS - INTRODUCTION AND SYMPOSIUM OVERVIEW.  35:S1-S2. 1994
  • Complex genetic disease: can genetic strategies in Alzheimer's disease and new genetic mechanisms be applied to epilepsy?.  35 Suppl 1:S20-S28. 1994
  • Identification of genetic defect of an epilepsy: strategies for therapeutic advances..  35 Suppl 1:S51-S57. 1994
  • Introduction and Symposium Overview.  35:S1-S1. 1994
  • MOLECULAR-GENETICS AND EPILEPSY - FOUNDATION FOR THERAPEUTIC ADVANCES - PANEL DISCUSSION.  35:S58-S62. 1994
  • Molecular Genetics and Epilepsy: Foundation for Therapeutic Advances. Proceedings of the 12th annual Merritt-Putnam Symposium. Seattle, Washington, December 5, 1992..  35 Suppl 1:S1-62. 1994
  • Panel discussion.  35. 1994
  • Panel discussion.  35. 1994
  • Neuroprotective effect of felbamate after kainic acid-induced status epilepticus..  34:359-366. 1993
  • Correlation between function and structure in "epileptic" human hippocampal tissue maintained in vitro..  34:54-60. 1993
  • Facilitation of infantile spasms by partial seizures..  34:97-109. 1993
  • Erratum: Double-blind randomized study comparing brand-name and generic phenytoin monotherapy (Epilepsia 33:2 (359-365)).  33:1156. 1992
  • Double-blind randomized study comparing brand-name and generic phenytoin monotherapy..  33:359-365. 1992
  • Temporal lobectomy and independent bitemporal interictal activity: what degree of lateralization is sufficient?.  32:195-201. 1991
  • Development of new pharmacological agents for epilepsy: lessons from the kindling model..  30 Suppl 1:S13-S18. 1989
  • RESEARCH IN EPILEPTOGENESIS - THE SEARCH FOR TOMORROWS ANTIEPILEPTIC DRUGS - PANEL DISCUSSION.  30:S64-S68. 1989
  • SEIZURE ACTIVITY INVITRO - INTERACTIONS IN A DUAL-FOCUS NETWORK.  29:217-217. 1988
  • INTERICTAL VERSUS ICTAL ACTIVITY - INDEPENDENT REGULATION IN LOW MAGNESIUM MODEL.  28:609-609. 1987
  • Differential effects of phenobarbital and pentobarbital on stimulus train-induced bursting in the hippocampal slice..  28:207-213. 1987
  • Infantile spasms following near-drowning: a report of two cases..  28:45-48. 1987
  • A METHOD OF PRODUCING SUSTAINED, RECURRENT ICTAL-LIKE EVENTS IN THE HIPPOCAMPAL SLICE.  27:630-630. 1986
  • Spontaneous rhythmic synchronous activity in epileptic human and normal monkey temporal lobe..  27:523-533. 1986
  • Valproate reduces excitability by blockage of sodium and potassium conductance..  27:177-182. 1986
  • Protracted epileptiform encephalopathy: an unusual form of partial complex status epilepticus..  26:563-571. 1985
  • BACLOFEN ATTENUATES LOCAL EPILEPTIFORM ACTIVITY IN HIPPOCAMPAL AREA CA3.  26:524-524. 1985
  • Discontinuation of antiepileptic drugs: Preliminary report of a prospective randomized study of two-year versus four-year seizure-free intervals, and nine-month versus six-week taper schedules.  23:437. 1982
  • Temporal lobectomy for epilepsy: mesial temporal herniation as an operative and prognostic finding..  22:623-629. 1981
  • Cellular localization of muscarinic cholinergic receptors in the dentate gyrus of hippocampal formation.  22:225-226. 1981
  • Potassium clearance and reactive gliosis in the alumina gel lesion..  18:499-506. 1977
  • Electroencephalographic and clinical studies of epilepsy during the maturation of the monkey..  3:137-150. 1962
  • Infantile spasms treated with the ketogenic diet: Prospective single-center experience in 104 consecutive infants.  51:1403-1407.
  • WHOLE GENOME SEQUENCING THE GENETIC ABSENCE EPILEPSY RAT FROM STRASBOURG, ITS RELATED NON-EPILEPTIC STRAIN AND F THEIR2 PROGENY 2017
  • BASELINE EEG PATTERN ON CONTINUOUS ICU EEG MONITORING AND INCIDENCE OF SEIZURES 2013
  • EVIDENCE THAT BUMETANIDE SUPPRESSES EPILEPTIFORM ACTIVITY IN ADULT PRIMATE CORTEX INDEPENDENT OF EFFECTS ON GABA-A SIGNALING 2009
  • NRXN1 VARIANTS ARE ASSOCIATED WITH BEHAVIORAL DIFFICULTY IN RESPONSE TO LEVETIRACETAM 2009
  • OPTICAL IMAGING OF HEMODYNAMIC RESPONSES TO NEURONAL ACTIVITY IN THE HUMAN CORTEX 2009
  • Use of levetiracetam in subarachnoid hemorrhage 2007
  • Brief seizures do not cause MRI abnormalities in rats 2007
  • A molecular mechanism for axonal targeting of KCNQ2/KCNQ3 potassium channels that are mutated in BFNC 2005
  • Chronic hypoxic preconditioning accentuates erythropoietin levels and prevents acute hypoxic seizure-associated memory impairment 2005
  • Dynamic regulation of hippocampal excitatory and feedforward inhibitory pathways during epileptogenesis 2005
  • Erythropoietin kinetics in plasma and cerebrospinal fluid of adult rats following high-dose recombinant erythropoietin. 2005
  • Real-time optical imaging of cortical interictal activity in primates and humans 2005
  • Seizure-related programmed cell death 2005
  • Topiramate related hyperthermia: A comparative study 2005
  • Furosemide and mannitol suppress epileptic activity in the human brain 2004
  • Neurotrophins and epileptogenesis 2004
  • Reducing TrkB levels protects hippocampal neurons from seizure-induced cell death 2004
  • Anatomical and temporal specific patterns of semaphorin gene expression in a rat model of limbic epileptogenesis. 1999
  • CA1 pyramidal cells may form recurrent excitatory synapses in kainic acid-treated hippocampus 1999
  • AUTOIMMUNE EPILEPSY - ASPECTS OF THE PATHOGENESIS OF RASMUSSENS ENCEPHALITIS 1995
  • CLINICAL AND ELECTROENCEPHALOGRAPHIC EVIDENCE FOR EPILEPTOGENIC AUTOANTIBODIES IN RASMUSSENS ENCEPHALITIS (RE) 1995
  • CORRELATION OF PATHOLOGICAL-CHANGES IN THE MESIAL TEMPORAL-LOBE AND SURGICAL OUTCOME 1995
  • DISEASE EXPRESSION AMONG PROBANDS WITH JUVENILE MYOCLINIC EPILEPSY AND THEIR FAMILY MEMBERS IN 2 POPULATION GROUPS 1995
  • LIMBIC EPILEPSY IN ALPHA-CALCIUM-CALMODULIN KINASE-II MUTANT MICE 1995
  • MOLECULAR-GENETIC ADVANCES - IMPLICATION FOR THERAPY OF EPILEPSY 1995
  • EEG PREDICTORS OF SUCCESS IN TEMPORAL LOBECTOMY - ANALYSIS OF 100 CASES 1988
  • MAGNETIC-RESONANCE IMAGING - PATHOLOGIC CORRELATION AFTER TEMPORAL LOBECTOMY 1988
  • MECHANISMS OF THE KINDLING MODEL 1988
  • NEOLOGISTIC SPEECH AUTOMATISMS DURING COMPLEX PARTIAL SEIZURES 1988
  • BIOCHEMICAL-EVIDENCE OF INCREASED NMDA RECEPTOR FUNCTION IN THE HIPPOCAMPUS OF KINDLED ANIMALS 1988
  • FACTORS PREDICTING SUCCESS IN TEMPORAL LOBECTOMY FOR COMPLEX PARTIAL SEIZURES 1987
  • THE KINDLING MODEL OF EPILEPSY 1987
  • ANTIEPILEPTIC DRUG ACTIONS IN EXPERIMENTAL-ANIMALS AND HUMANS 1986
  • SUBSTANTIA-NIGRA CONTROL OF SEIZURE PROPAGATION - ROLE OF NORADRENERGIC NEURONS 1986
  • USEFULNESS OF MAGNETIC-RESONANCE-IMAGING IN PRESURGICAL EVALUATION OF INTRACTABLE COMPLEX PARTIAL SEIZURES 1986
  • EVIDENCE IMPLICATING THE SUBSTANTIA NIGRA IN PROPAGATION OF LIMBIC SEIZURES - LESSONS FROM THE KINDLING MODEL 1985
  • INVESTIGATION OF MECHANISM BY WHICH SUBSTANTIA NIGRA PROPAGATES LIMBIC SEIZURES 1985
  • UNILATERAL KINDLING INDUCES A BILATERAL INCREASE IN TEMPORAL, BUT NOT SEPTAL, HIPPOCAMPAL EXCITABILITY 1985
  • BENZODIAZEPINE RECEPTOR INCREASES FOLLOWING REPEATED SEIZURES - EVIDENCE FOR LOCALIZATION TO DENTATE GRANULE CELLS 1983
  • LIMBIC SEIZURES DOWN-REGULATE MUSCARINIC CHOLINERGIC RECEPTORS IN HIPPOCAMPAL-FORMATION 1983